Titre : Maladies de la moelle osseuse

Maladies de la moelle osseuse : Questions médicales fréquentes

Termes MeSH sélectionnés :

Microcirculation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Maladies de la moelle osseuse : Questions médicales les plus fréquentes", "headline": "Maladies de la moelle osseuse : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Maladies de la moelle osseuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-15", "dateModified": "2025-04-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Maladies de la moelle osseuse" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hémopathies", "url": "https://questionsmedicales.fr/mesh/D006402", "about": { "@type": "MedicalCondition", "name": "Hémopathies", "code": { "@type": "MedicalCode", "code": "D006402", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Aplasies médullaires", "alternateName": "Bone Marrow Failure Disorders", "url": "https://questionsmedicales.fr/mesh/D000080983", "about": { "@type": "MedicalCondition", "name": "Aplasies médullaires", "code": { "@type": "MedicalCode", "code": "D000080983", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.223" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anémie aplasique", "alternateName": "Anemia, Aplastic", "url": "https://questionsmedicales.fr/mesh/D000741", "about": { "@type": "MedicalCondition", "name": "Anémie aplasique", "code": { "@type": "MedicalCode", "code": "D000741", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.223.250" } } } ] }, { "@type": "MedicalWebPage", "name": "Maladies myélodysplasiques-myéloprolifératives", "alternateName": "Myelodysplastic-Myeloproliferative Diseases", "url": "https://questionsmedicales.fr/mesh/D054437", "about": { "@type": "MedicalCondition", "name": "Maladies myélodysplasiques-myéloprolifératives", "code": { "@type": "MedicalCode", "code": "D054437", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.615" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Leucémie myélomonocytaire juvénile", "alternateName": "Leukemia, Myelomonocytic, Juvenile", "url": "https://questionsmedicales.fr/mesh/D054429", "about": { "@type": "MedicalCondition", "name": "Leucémie myélomonocytaire juvénile", "code": { "@type": "MedicalCode", "code": "D054429", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.615.520" } } } ] }, { "@type": "MedicalWebPage", "name": "Syndromes myélodysplasiques", "alternateName": "Myelodysplastic Syndromes", "url": "https://questionsmedicales.fr/mesh/D009190", "about": { "@type": "MedicalCondition", "name": "Syndromes myélodysplasiques", "code": { "@type": "MedicalCode", "code": "D009190", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anémie réfractaire", "alternateName": "Anemia, Refractory", "url": "https://questionsmedicales.fr/mesh/D000753", "about": { "@type": "MedicalCondition", "name": "Anémie réfractaire", "code": { "@type": "MedicalCode", "code": "D000753", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625.062" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anémie réfractaire avec excès de blastes", "alternateName": "Anemia, Refractory, with Excess of Blasts", "url": "https://questionsmedicales.fr/mesh/D000754", "about": { "@type": "MedicalCondition", "name": "Anémie réfractaire avec excès de blastes", "code": { "@type": "MedicalCode", "code": "D000754", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625.062.080" } } } ] }, { "@type": "MedicalWebPage", "name": "Anémie réfractaire avec excès de blastes", "alternateName": "Anemia, Refractory, with Excess of Blasts", "url": "https://questionsmedicales.fr/mesh/D000754", "about": { "@type": "MedicalCondition", "name": "Anémie réfractaire avec excès de blastes", "code": { "@type": "MedicalCode", "code": "D000754", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625.062.080" } } }, { "@type": "MedicalWebPage", "name": "Anémie sidéroblastique", "alternateName": "Anemia, Sideroblastic", "url": "https://questionsmedicales.fr/mesh/D000756", "about": { "@type": "MedicalCondition", "name": "Anémie sidéroblastique", "code": { "@type": "MedicalCode", "code": "D000756", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625.070" } } }, { "@type": "MedicalWebPage", "name": "Hémoglobinurie paroxystique", "alternateName": "Hemoglobinuria, Paroxysmal", "url": "https://questionsmedicales.fr/mesh/D006457", "about": { "@type": "MedicalCondition", "name": "Hémoglobinurie paroxystique", "code": { "@type": "MedicalCode", "code": "D006457", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625.460" } } } ] }, { "@type": "MedicalWebPage", "name": "Syndromes myéloprolifératifs", "alternateName": "Myeloproliferative Disorders", "url": "https://questionsmedicales.fr/mesh/D009196", "about": { "@type": "MedicalCondition", "name": "Syndromes myéloprolifératifs", "code": { "@type": "MedicalCode", "code": "D009196", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.636" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anémie myélophtisique", "alternateName": "Anemia, Myelophthisic", "url": "https://questionsmedicales.fr/mesh/D000750", "about": { "@type": "MedicalCondition", "name": "Anémie myélophtisique", "code": { "@type": "MedicalCode", "code": "D000750", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.636.085" } } }, { "@type": "MedicalWebPage", "name": "Leucémie érythroblastique aigüe", "alternateName": "Leukemia, Erythroblastic, Acute", "url": "https://questionsmedicales.fr/mesh/D004915", "about": { "@type": "MedicalCondition", "name": "Leucémie érythroblastique aigüe", "code": { "@type": "MedicalCode", "code": "D004915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.636.276" } } }, { "@type": "MedicalWebPage", "name": "Myélofibrose primitive", "alternateName": "Primary Myelofibrosis", "url": "https://questionsmedicales.fr/mesh/D055728", "about": { "@type": "MedicalCondition", "name": "Myélofibrose primitive", "code": { "@type": "MedicalCode", "code": "D055728", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.636.765" } } }, { "@type": "MedicalWebPage", "name": "Thrombocytose", "alternateName": "Thrombocytosis", "url": "https://questionsmedicales.fr/mesh/D013922", "about": { "@type": "MedicalCondition", "name": "Thrombocytose", "code": { "@type": "MedicalCode", "code": "D013922", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.636.860" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Maladies de la moelle osseuse", "alternateName": "Bone Marrow Diseases", "code": { "@type": "MedicalCode", "code": "D001855", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sebastian Berg", "url": "https://questionsmedicales.fr/author/Sebastian%20Berg", "affiliation": { "@type": "Organization", "name": "Division of Pediatric Radiology, Department of Radiology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany." } }, { "@type": "Person", "name": "Charlotte Niemeyer", "url": "https://questionsmedicales.fr/author/Charlotte%20Niemeyer", "affiliation": { "@type": "Organization", "name": "Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany." } }, { "@type": "Person", "name": "Ioannis Mitroulis", "url": "https://questionsmedicales.fr/author/Ioannis%20Mitroulis", "affiliation": { "@type": "Organization", "name": "Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.)." } }, { "@type": "Person", "name": "George Hajishengallis", "url": "https://questionsmedicales.fr/author/George%20Hajishengallis", "affiliation": { "@type": "Organization", "name": "Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia (G.H.)." } }, { "@type": "Person", "name": "Triantafyllos Chavakis", "url": "https://questionsmedicales.fr/author/Triantafyllos%20Chavakis", "affiliation": { "@type": "Organization", "name": "Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.)." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Workload and sex effects in comprehensive assessment of cutaneous microcirculation.", "datePublished": "2023-05-14", "url": "https://questionsmedicales.fr/article/37192688", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.mvr.2023.104547" } }, { "@type": "ScholarlyArticle", "name": "Glomerular microcirculation: Implications for diabetes, preeclampsia, and kidney injury.", "datePublished": "2023-09-09", "url": "https://questionsmedicales.fr/article/37688412", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/apha.14048" } }, { "@type": "ScholarlyArticle", "name": "Molecular mechanisms of endothelial dysfunction in coronary microcirculation dysfunction.", "datePublished": "2023-07-19", "url": "https://questionsmedicales.fr/article/37466848", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11239-023-02862-2" } }, { "@type": "ScholarlyArticle", "name": "Angiography derived assessment of the coronary microcirculation: is it ready for prime time?", "datePublished": "2022-08-09", "url": "https://questionsmedicales.fr/article/35899781", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/14779072.2022.2098117" } }, { "@type": "ScholarlyArticle", "name": "Alterations in ocular microcirculation and oxygen metabolism in patients with lipemia retinalis.", "datePublished": "2022-07-06", "url": "https://questionsmedicales.fr/article/35794613", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12886-022-02515-7" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Hémopathies et maladies lymphatiques", "item": "https://questionsmedicales.fr/mesh/D006425" }, { "@type": "ListItem", "position": 3, "name": "Hémopathies", "item": "https://questionsmedicales.fr/mesh/D006402" }, { "@type": "ListItem", "position": 4, "name": "Maladies de la moelle osseuse", "item": "https://questionsmedicales.fr/mesh/D001855" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Maladies de la moelle osseuse - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Maladies de la moelle osseuse", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Maladies de la moelle osseuse", "description": "Comment diagnostiquer une maladie de la moelle osseuse ?\nQuels tests sont utilisés pour évaluer la moelle osseuse ?\nQuels signes indiquent une maladie de la moelle osseuse ?\nQuelle imagerie est utilisée pour la moelle osseuse ?\nLes tests sanguins peuvent-ils détecter des maladies de la moelle ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Microcirculation&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Maladies de la moelle osseuse", "description": "Quels sont les symptômes courants des maladies de la moelle osseuse ?\nComment la moelle osseuse affecte-t-elle le système immunitaire ?\nLes maladies de la moelle osseuse causent-elles des saignements ?\nPeut-on avoir des douleurs osseuses avec ces maladies ?\nLes symptômes varient-ils selon le type de maladie ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Microcirculation&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Maladies de la moelle osseuse", "description": "Peut-on prévenir les maladies de la moelle osseuse ?\nQuels facteurs de risque sont évitables ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLe tabagisme influence-t-il les maladies de la moelle ?\nLes examens réguliers aident-ils à la prévention ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Microcirculation&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Maladies de la moelle osseuse", "description": "Quels traitements sont disponibles pour les maladies de la moelle osseuse ?\nLa greffe de moelle osseuse est-elle efficace ?\nQuels médicaments sont utilisés pour traiter ces maladies ?\nLa radiothérapie est-elle une option de traitement ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Microcirculation&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Maladies de la moelle osseuse", "description": "Quelles complications peuvent survenir avec ces maladies ?\nLes maladies de la moelle osseuse augmentent-elles le risque de cancer ?\nComment les infections sont-elles liées à ces maladies ?\nLes saignements peuvent-ils être graves ?\nQuelles sont les conséquences d'une insuffisance médullaire ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Microcirculation&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Maladies de la moelle osseuse", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de maladies de la moelle ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe mode de vie peut-il affecter le risque ?\nLes infections virales sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Microcirculation&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une maladie de la moelle osseuse ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par des analyses sanguines, biopsies et examens d'imagerie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la moelle osseuse ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'aspiration de moelle osseuse et des tests génétiques." } }, { "@type": "Question", "name": "Quels signes indiquent une maladie de la moelle osseuse ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent fatigue, infections fréquentes et saignements anormaux." } }, { "@type": "Question", "name": "Quelle imagerie est utilisée pour la moelle osseuse ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM et la tomodensitométrie sont souvent utilisées pour visualiser la moelle." } }, { "@type": "Question", "name": "Les tests sanguins peuvent-ils détecter des maladies de la moelle ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent révéler des anomalies dans les cellules sanguines." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des maladies de la moelle osseuse ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, fièvre, ecchymoses et douleurs osseuses." } }, { "@type": "Question", "name": "Comment la moelle osseuse affecte-t-elle le système immunitaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Une moelle osseuse malade peut réduire la production de globules blancs, affaiblissant l'immunité." } }, { "@type": "Question", "name": "Les maladies de la moelle osseuse causent-elles des saignements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des saignements excessifs en raison d'une faible production de plaquettes." } }, { "@type": "Question", "name": "Peut-on avoir des douleurs osseuses avec ces maladies ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs osseuses peuvent survenir en raison de l'infiltration de cellules anormales." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de maladie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type de maladie de la moelle osseuse." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies de la moelle osseuse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies sont héréditaires, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Quels facteurs de risque sont évitables ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition à des produits chimiques toxiques peut réduire le risque." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé de la moelle osseuse et du sang." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il les maladies de la moelle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque pour plusieurs maladies hématologiques." } }, { "@type": "Question", "name": "Les examens réguliers aident-ils à la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les maladies de la moelle osseuse ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent chimiothérapie, radiothérapie et greffe de moelle osseuse." } }, { "@type": "Question", "name": "La greffe de moelle osseuse est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être curative pour certaines maladies, mais comporte des risques." } }, { "@type": "Question", "name": "Quels médicaments sont utilisés pour traiter ces maladies ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les agents immunosuppresseurs et les facteurs de croissance sont utilisés." } }, { "@type": "Question", "name": "La radiothérapie est-elle une option de traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la radiothérapie peut être utilisée pour traiter certaines formes de cancer de la moelle." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont souvent adaptés en fonction du type et de la gravité de la maladie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec ces maladies ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent infections, saignements et insuffisance médullaire." } }, { "@type": "Question", "name": "Les maladies de la moelle osseuse augmentent-elles le risque de cancer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies de la moelle osseuse peuvent augmenter le risque de cancers secondaires." } }, { "@type": "Question", "name": "Comment les infections sont-elles liées à ces maladies ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une moelle osseuse défaillante peut entraîner une immunodéficience, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Les saignements peuvent-ils être graves ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des saignements graves peuvent survenir en raison d'une faible production de plaquettes." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une insuffisance médullaire ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'insuffisance médullaire peut entraîner une anémie sévère, des infections et des hémorragies." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'exposition à des radiations, des produits chimiques et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de maladies de la moelle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout après 60 ans." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles de la moelle osseuse." } }, { "@type": "Question", "name": "Le mode de vie peut-il affecter le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme et une mauvaise alimentation peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les infections virales sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de maladies de la moelle." } } ] } ] }

Sources (573 au total)

Workload and sex effects in comprehensive assessment of cutaneous microcirculation.

Workload and sex-related differences have been proposed as factors of importance when evaluating the microcirculation. Simultaneous assessments with diffuse reflectance spectroscopy (DRS) and laser Do... In 24 healthy participants (aged 20 to 30 years, 12 females), cutaneous microcirculation was assessed by LDF and DRS at baseline, during a workload generated by cycling at 75 to 80 % of maximal age-pr... Females had significantly lower RBC tissue fraction and total perfusion in forearm skin microcirculation at all phases (baseline, workload, and recovery). All microvascular parameters increased signif... Compared to a resting state, all studied microcirculation measures increased during cycling. For perfusion, this was mainly due to increased speed, and only to a minor extent due to increased RBC tiss...

Angiography derived assessment of the coronary microcirculation: is it ready for prime time?

Non-obstructive coronary arteries (NOCA) are present in 39.7% to 62.4% of patients who undergo elective angiography. Coronary microcirculation (<400 µm) is not visible on angiography therefore functio... In this review, we revisit the pathophysiology, clinical importance, and invasive assessment of the coronary microcirculation, and discuss angiography-derived indices of microvascular resistance. A co... The coronary microvasculature plays an important role in flow autoregulation and metabolic regulation. Invasive assessment of microvascular resistance is a validated modality with independent prognost...

Alterations in ocular microcirculation and oxygen metabolism in patients with lipemia retinalis.

The study aims to assess the alterations in retinal oxygen saturation and retinal and choroidal blood flow in lipemia retinalis.... This was a cross-sectional study on 10 eyes (5 patients) with history of lipemia retinalis. The study comprised 10 eyes with documented history of lipemia retinalis and 10 participants as healthy cont... Patients with untreated lipemia retinalis had a significantly higher retinal arteriolar and venular oxygen saturation than that of the other two groups (p < 0.001). Moreover, patients with untreated l... There was a significant alteration in retinal oximetry, in untreated lipemia retinalis, and in retinal blood flow, in both the resolved and untreated groups. The increase in retinal blood flow and oxy...

Direct assessment of microcirculation in shock: a randomized-controlled multicenter study.

Shock is a life-threatening condition characterized by substantial alterations in the microcirculation. This study tests the hypothesis that considering sublingual microcirculatory perfusion variables... This randomized, prospective clinical multicenter trial-recruited patients with an arterial lactate value above two mmol/L, requiring vasopressors despite adequate fluid resuscitation, regardless of t... Overall, we included 141 patients with cardiogenic (n = 77), post cardiac surgery (n = 27), or septic shock (n = 22). 69 patients were randomized to the intervention and 72 to routine care. No serious... Integrating sublingual microcirculatory perfusion variables in the therapy plan resulted in treatment changes that do not improve survival at all....

Association between microcirculation in spontaneous breathing trial and extubation success.

This study assessed the association between changes in sublingual microcirculation after a spontaneous breathing trial (SBT) and successful extubation.... Sublingual microcirculation was assessed using an incident dark-field video microscope before and after each SBT and before extubation. Microcirculatory parameters before the SBT, at the end of the SB... Forty-seven patients were enrolled and analysed in this study (34 patients in the successful extubation group and 13 patients in the failed extubation group). At the end of the SBT, the weaning parame... More patients are required to investigate the difference between baseline microcirculation before a successful SBT and the change in microcirculation at the end of the SBT between the successful and f...

Use of new microcirculation software allows the demonstration of dermis vascularization.

Current ultrasound (US) Doppler techniques cannot demonstrate the vascularization of the dermis. The purpose of this study was to investigate whether the new Superb Vascular Imaging (SMI) and Microvas... By using US, 50 healthy volunteers were evaluated at level of five body areas: forehead, forearm, palm, buttock, and thigh. Two off-site operators evaluated the images to assess the difference between... SMI scored grade 0 in 0% of body areas, grade 1 in 58%, grade 2 in 33%, and grade 3 in 9%. In comparison with SMI, PD scored grade 0 in 38% of body areas, grade 1 in 56%, grade 2 in 6%, and grade 3 in... We found both SMI and MV-Flow to be superior to PD imaging and capable to demonstrate normal vascularization of the dermis....

The sublingual microcirculation and frailty index in chronic kidney disease patients.

To examine the relationship between sublingual microcirculatory measures and frailty index in those attending a kidney transplant assessment clinic.... Patients recruited had their sublingual microcirculation taken using sidestream dark field videomicroscopy (MicroScan, Micro Vision Medical, Amsterdam, the Netherlands) and their frailty index score u... A total of 44 patients were recruited with two being excluded due to microcirculatory image quality scores exceeding 10. The frailty index score indicated significant correlations with total vessel de... There is a relationship between the frailty index and microcirculatory health in those attending a kidney transplant assessment clinic, that is not confounded by age. These findings suggest that the i...